Alterity Therapeutics
ATHE
7 hedge funds and large institutions have $260K invested in Alterity Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
13% more capital invested
Capital invested by funds: $231K → $260K (+$29.8K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
42% less funds holding
Funds holding: 12 → 7 (-5)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$104K |
| 2 |
TLCM
Twin Lakes Capital Management
Redwood Shores,
California
|
+$20.2K |
| 3 |
Morgan Stanley
New York
|
+$3.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$34K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$244 |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$140 |
| 4 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
-$52 |
| 5 |
CASC
Coppell Advisory Solutions Corp
Coppell,
Texas
|
-$52 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $148K | +$3.57K | +1,049 | +2% |
|
|
OMC
2
Old Mission Capital
Chicago,
Illinois
| $94.5K | +$104K | +30,427 | +843% |
|
|
TLCM
3
Twin Lakes Capital Management
Redwood Shores,
California
| $16.4K | +$20.2K | +5,925 | New |
|
|
PCA
4
Providence Capital Advisors
Charlotte,
North Carolina
| $555 | – | – | – |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $223 | -$3 | -1 | -1% |
|
|
SWM
6
Sugarloaf Wealth Management
Duluth,
Georgia
| $92 | – | – | – |
|
|
SPIA
7
Steward Partners Investment Advisory
New York
| $17 | – | – | – |
|
|
8
Millennium Management
New York
| – | -$34K | -9,684 | Closed |
|
|
9
BNP Paribas Financial Markets
Paris,
France
| – | -$244 | -70 | Closed |
|
|
10
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$140 | -40 | Closed |
|
|
CAS
11
Coppell Advisory Solutions
Coppell,
Texas
| – | -$52 | -15 | Closed |
|
|
CASC
12
Coppell Advisory Solutions Corp
Coppell,
Texas
| – | -$52 | -15 | Closed |
|
ATHE Hedge Fund Activity: Q1 2023 in Review
7 of the 6,278 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q1 2023, worth a combined $260K — up 13% from $231K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ATHE and 1 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Old Mission Capital, adding an estimated $104K. The largest seller was Millennium Management, exiting entirely with an estimated $34K sold.
- 7 institutional investors held Alterity Therapeutics (ATHE) as of Q1 2023, down from 12 in Q4 2022.
- Funds reported $260K of Alterity Therapeutics stock for Q1 2023, up 13% quarter-over-quarter.
- 1 fund opened new Alterity Therapeutics positions in Q1 2023 and 5 closed out, a net change of -4 holders.
- The largest Alterity Therapeutics buyer in Q1 2023 was Old Mission Capital, an estimated $104K added.
- The largest Alterity Therapeutics seller in Q1 2023 was Millennium Management, an estimated $34K sold.
Based on aggregated 13F filings for Q1 2023.